Dear Sir/Madam, Pursuant to code of Conduct to regulate, monitor and report Trading by insiders (''Code''), please find attached Intimation regarding closure of Trading Window. You ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has informed the stock exchanges that the trading window for insiders dealing in the company's securities will be closed starting January 1, 2026. The window will reopen 48 hours after the company declares its financial results for the quarter ended December 31, 2025 (Q3 FY26). This is a standard regulatory compliance filing under SEBI's insider trading regulations, signed by Director Davender Singh. No specific financial figures or material business developments are disclosed in this filing.
This is a routine compliance announcement and typically has no direct impact on the stock price. However, it signals that the company's Q3 FY26 results are likely to be announced in the coming weeks, which investors should watch for as the next potential catalyst.